Metro Healthcare Berhad (KLSE:METRO)
Malaysia · Delayed Price · Currency is MYR 0.2000
-0.0100 (-4.76%)
At close: Sep 2, 2026
Metro Healthcare Berhad Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 51.12 | 50.42 | 48.65 | 44.69 | 40.27 | 42.26 | |
Revenue Growth | 6.69% | 3.63% | 8.87% | 10.96% | -4.70% | 49.14% |
Cost of Revenue | 31.77 | 31.46 | 28.92 | 26.61 | 24.27 | 22.16 |
Gross Profit | 19.35 | 18.96 | 19.73 | 18.08 | 16.01 | 20.09 |
Other Operating Expenses | 11.48 | 12.02 | 12.32 | 9.21 | 8.71 | 8.11 |
Operating Expenses | 11.48 | 12.02 | 12.32 | 9.21 | 8.71 | 8.11 |
Operating Income | 7.87 | 6.94 | 7.4 | 8.87 | 7.3 | 11.98 |
Interest Expense | -0.66 | -0.62 | -0.69 | -0.73 | -0.4 | -0.37 |
Interest & Investment Income | 1.64 | 1.64 | 0.46 | 0.21 | 0.17 | 0.11 |
EBT Excluding Unusual Items | 8.87 | 7.96 | 7.17 | 8.35 | 7.07 | 11.72 |
Gain (Loss) on Sale of Investments | 0.02 | 0.02 | - | - | 0.08 | 0.79 |
Gain (Loss) on Sale of Assets | 0.02 | 0.02 | - | 0.03 | 0.22 | 0.02 |
Other Unusual Items | 0.16 | 0.16 | - | 0.16 | 0 | 0.07 |
Pretax Income | 9.07 | 8.17 | 7.17 | 8.54 | 7.38 | 12.6 |
Income Tax Expense | 2.22 | 2.31 | 2.61 | 2.29 | 2.36 | 3.17 |
Net Income | 6.86 | 5.86 | 4.56 | 6.25 | 5.02 | 9.44 |
Net Income to Common | 6.86 | 5.86 | 4.56 | 6.25 | 5.02 | 9.44 |
Net Income Growth | 170.50% | 28.56% | -27.02% | 24.56% | -46.85% | 72.32% |
Shares Outstanding (Basic) | 979 | 979 | 979 | 822 | 822 | 822 |
Shares Outstanding (Diluted) | 979 | 979 | 979 | 822 | 827 | 822 |
Shares Change | -7.41% | - | 19.05% | -0.55% | 0.55% | 1.82% |
EPS (Basic) | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
EPS (Diluted) | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 |
EPS Growth | 192.28% | 28.56% | -38.70% | 24.56% | -46.86% | 69.25% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 7.06 | 7.59 | 5.58 | 7.38 | 4.67 | 7.21 |
Free Cash Flow Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Dividend Per Share | 0.005 | 0.006 | 0.005 | 0.005 | 0.005 | 0.002 |
Dividend Growth | 25.00% | 20.37% | 1.89% | 6.00% | 212.50% | 6.67% |
Gross Margin | 37.85% | 37.61% | 40.55% | 40.46% | 39.74% | 47.55% |
Operating Margin | 15.40% | 13.77% | 15.22% | 19.85% | 18.12% | 28.36% |
Profit Margin | 13.41% | 11.63% | 9.37% | 13.98% | 12.46% | 22.33% |
Free Cash Flow Margin | 13.81% | 15.06% | 11.46% | 16.52% | 11.60% | 17.05% |
EBITDA | 11.19 | 10.37 | 10.62 | 11.66 | 9.97 | 13.99 |
EBITDA Margin | 21.89% | 20.57% | 21.84% | 26.10% | 24.76% | 33.10% |
D&A For EBITDA | 3.32 | 3.43 | 3.22 | 2.79 | 2.68 | 2.01 |
EBIT | 7.87 | 6.94 | 7.4 | 8.87 | 7.3 | 11.98 |
EBIT Margin | 15.40% | 13.77% | 15.22% | 19.85% | 18.12% | 28.36% |
Effective Tax Rate | 24.45% | 28.25% | 36.43% | 26.86% | 32.01% | 25.12% |